chrX-102749938-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001142524.2(GPRASP3):āc.943A>Gā(p.Lys315Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000927 in 1,208,280 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 36 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001142524.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP3 | NM_001142524.2 | c.943A>G | p.Lys315Glu | missense_variant | 4/4 | ENST00000457056.6 | |
ARMCX5-GPRASP2 | NR_146584.3 | n.1218+28847A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP3 | ENST00000457056.6 | c.943A>G | p.Lys315Glu | missense_variant | 4/4 | 4 | NM_001142524.2 | P1 | |
ARMCX5-GPRASP2 | ENST00000652409.1 | c.943A>G | p.Lys315Glu | missense_variant | 8/8 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000713 AC: 8AN: 112271Hom.: 0 Cov.: 23 AF XY: 0.0000871 AC XY: 3AN XY: 34425
GnomAD3 exomes AF: 0.000128 AC: 23AN: 179867Hom.: 0 AF XY: 0.0000929 AC XY: 6AN XY: 64587
GnomAD4 exome AF: 0.0000949 AC: 104AN: 1096009Hom.: 0 Cov.: 31 AF XY: 0.0000913 AC XY: 33AN XY: 361577
GnomAD4 genome AF: 0.0000713 AC: 8AN: 112271Hom.: 0 Cov.: 23 AF XY: 0.0000871 AC XY: 3AN XY: 34425
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2022 | The c.943A>G (p.K315E) alteration is located in exon 4 (coding exon 1) of the BHLHB9 gene. This alteration results from a A to G substitution at nucleotide position 943, causing the lysine (K) at amino acid position 315 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at